Clinical Trials
3 trialsNCT00116454 2026-04-03
Lipiocis
ANRS, Emerging Infectious Diseases
Phase 3 Completed
NCT00913757 2020-05-04
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
National Institutes of Health Clinical Center (CC)
Completed
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed